SavedAdd your journal

Journals / KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi / 2021 / Cilt: 2 - Sayı: 2

COVID 19: The Relationship Among Angiotensin-Converting Enzyme 2 (ACE 2), Renin-Angiotensin-Aldesterone System (RAS), and Chronic Diseases

COVID 19: Anjiyotensin Dönüştürücü Enzim 2 (ACE2), Renin-Anjiyotensin-Aldosteron Sistemi (RAAS) ve Kronik Hastalıklar Arasındaki İlişki

Meryem TOPAL
Sevim Beyza ÖZTÜRK SARIKAYA
Fevzi TOPAL
Pages
61–72
Publication Date
2021-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our study, the reasons why this virus affects chronic patients more than other people and its relationship with ACE2, Renin-Angiotensin-Aldosterone metabolism are tried to be elucidated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:SARS CoVID-2 (COVID-19), the seventh type of coronavirus that causes infections in humans, has become a major threat to human life worldwide.
📊
Key Findings & Data:Therefore, the study describes the relationship of the COVID-19 virus with chronic diseases.
💡
Conclusion & Impact:In our study, the reasons why this virus affects chronic patients more than other people and its relationship with ACE2, Renin-Angiotensin-Aldosterone metabolism are tried to be elucidated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:ACE 2 · Kronik hastalık · Corona virüs

Abstract

SARS CoVID-2 (COVID-19), the seventh type of coronavirus that causes infections in humans, has become a major threat to human life worldwide. The virus, which emerged in Wuhan and spread from there to the whole world, has become a major threat, especially in elderly and chronic patients (hypertension, Diabetes Mellitus (DM), heart disease) today. It is very important to know why this virus is more effective in chronic patients, in the prevention or treatment of the disease. Therefore, the study describes the relationship of the COVID-19 virus with chronic diseases. Angiotensin-converting enzyme (ACE2) is particularly involved in vital organs such as the kidney, heart, liver, and lungs. The entry of the COVID-19 virus into the cell is through the ACE2 enzyme. In our study, the reasons why this virus affects chronic patients more than other people and its relationship with ACE2, Renin-Angiotensin-Aldosterone metabolism are tried to be elucidated.

Özet

İnsanlarda enfeksiyonlara neden olan yedinci tip koronavirüs olan SARS CoVID-2 (COVID-19), dünya çapında insan yaşamı için büyük bir tehdit haline gelmiştir. Wuhan’da ortaya çıkan ve oradan da tüm dünyaya yayılan virüs, bugün özellikle yaşlı ve kronik hastalarda (hipertansiyon, Diabetes Mellitus (DM), kalp hastalığı) büyük bir tehdit haline gelmiştir. Bu virüsün niçin kronik hastalarda daha etkili olduğunu bilmek hastalığın önlenmesi veya tedavisinde oldukça önemlidir. Bu nedenle çalışmada COVID-19 virüsünün kronik hastalıklar ile olan ilişkisi anlatılmaktadır. Angiotensin-converting enzyme (ACE2), özellikle böbrek, kalp, karaciğer, ve akciğerler gibi yaşam için önemli organlarda rol almaktadır. COVID-19 virüsünün hücre içerisine girişi ise ACE2 enzimiyledir. Çalışmamızda bu virüsün kronik hastaları diğer insanlardan daha fazla etkilenmesinin nedenleri ve ACE2, Renin-Anjiyotensin-Aldosteron metabolizması ile ilişkisi aydınlatılmaya çalışılmaktadır.

🔖

Cite This Article

TOPAL, M., SARIKAYA, S. B. Ö., TOPAL, F. (2021). COVID 19: The Relationship Among Angiotensin-Converting Enzyme 2 (ACE 2), Renin-Angiotensin-Aldesterone System (RAS), and Chronic Diseases. KTO Karatay Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 2 - Sayı: 2, 61–72. https://ajindex.com/articles/787344

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ahn, D. G., Shin, H. J., Kim, M. H.,. & Kim, S. J. (2020).
  2. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID 19) Journal of Microbiology and Biotechnology,, 30(3), 313-324.
  3. Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Jr Burnett, J. C., Lorens-Cortes, C.,. & Sturrock, E. D. (2019). Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev., 71(539-570).
  4. Baker, K. M., & Kumar, R. (2006). Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am. J. Physiol. Cell Physiol, 291, 995-1001.
  5. Baur, L. H. B., Schipperheyn, J. J., Laarse, A. v. d., Souverijn, J. H. M., Frolich, M., & de Groot, A. (1995). Combining salicylate and enalapril in patients with coronary artery disease and heart failure. Br. Heart. J., 73, 227-236.
  6. Boehm, M., & Nabel, E. G. (2002). Angiotensin-converting enzyme 2-a new cardiac regulator. N. Engl. J. Med., 347, 1795-1797.
  7. Burnier, M. (2001). Angiotensin II type 1 receptor blockers. Circulation, 103, 904-912.
  8. Chen, Y., Guo, Y., Pan, Y., & Zhao, Z. J. (2020). Structure analysis of the receptor binding of 2019-nCoV. Biochem. Biophys. Res. Commun., 525, 135-140.
  9. Corvol, P., Williams, T. A., & Soubrier, F. (1995). Peptidyl dipeptidase A: angiotensin I-converting enzyme. Methods Enzymol., 248, 283-305.
  10. Çiçek, Z., Akıllıoğlu, K., & Doğan, A. (2019). Local and Systemic Renin Angiotensin System. Archives Medical Review Journal, 28(4), 259-269.
  11. Danser, A. H. J., Epstein, M., & Batlle, D. (2020). Renin-angiotensin system blockers and the COVID-19 pandemic at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension, 75, 1382-1385.
  12. Devaux, C. A., Rolain, J. M., & Raoult, D. (2020). ACE2 Receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J. Microbiol. Immunol. Infect., 53, 425-435.
  13. Diao, B., Wang, C., Wang, R., Feng, Z., Tan, Y., Wang, H.,. & Chen, Y. (2020). Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Front. Immunol., 11, 827. Fehr, A. R., & Perlman, S. (2015). Coronaviruses: An overview of their replication and pathogenesis. Methods Mol. Biol., 1282, 1-23.
  14. Ferrario, C. M. J. (2006). Role of angiotensin II in cardiovascular disease-therapeutic implications of more than a century of research. Renin Ang